Association of metabolites on ischemic stroke subtypes: a 2-sample Mendelian randomization study
Metabolites show significant potential as circulating metabolic biomarkers and offer promise for clinical applications in the prevention and screening of IS subtypes. These discoveries notably advance our comprehension of the molecular processes specific to IS subtypes and create avenues for investigating targeted treatment approaches in the future.
Authors
- Weikai Zhu
- Anning Wang (ORCID: https://orcid.org/0000-0002-9036-9914)
- Jingyuan Zhang (ORCID: https://orcid.org/0000-0003-2268-9526)
- Luping Ma
- Yanyan Zhao (ORCID: https://orcid.org/0009-0005-8467-2801)
- Hui Shen (ORCID: https://orcid.org/0000-0002-2186-9720)
Institutions
- Dalian Medical University (CN)
- Dalian Dermatosis Hospital (CN)
- First Affiliated Hospital of Dalian Medical University (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2024-08-29
- DOI
- https://doi.org/10.3389/fneur.2024.1417357
- Citations
- 3
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.70
Funders
- Gujarat Council on Science and Technology